Inside a great airplane pilot data, Sullivan and you will colleagues (2013) evaluated using endoscopic ambition procedures for treating carrying excess fat

Inside a great airplane pilot data, Sullivan and you will colleagues (2013) evaluated using endoscopic ambition procedures for treating carrying excess fat

AspireAssist Ambition Procedures

This method entails endoscopic placement of a gastrostomy tube (A-Tube) and the AspireAssist siphon assembly (Aspire Bariatrics, King of Prussia, PA) to aspirate gastric contents 20 minutes after meal consumption. These researchers performed a study of 18 obese subjects who were randomly assigned (2:1) to groups that underwent aspiration therapy for 1 year plus lifestyle therapy (n = 11; mean BMI, 42.6 ± 1.4 kg/m(2)) or lifestyle therapy only (n = 7; mean BMI, 43.4 ± 2.0 kg/m(2)). Lifestyle intervention comprised a 15-session diet and behavioral education program; 10 of the 11 subjects who underwent aspiration therapy and 4 of the 7 subjects who underwent lifestyle therapy completed the 1st year of the study. After 1 year, subjects in the aspiration therapy group lost 18.6 % ± 2.3 % of their body weight (49.0 % ± 7.7 % of EWL) and those in the lifestyle therapy group lost 5.9 % ± 5.0 % (14.9 % ± 12.2 % of EWL) (p < 0.04); 7 of the 10 subjects in the aspiration therapy group completed an additional year of therapy and maintained a 20.1 % ± 3.5 % body weight loss (54.6 % ± 12.0 % of EWL). There were no AEs of aspiration therapy on eating behavior and no evidence of compensation for aspirated calories with increased food intake. No episodes of binge eating in the aspiration therapy group or serious AEs were reported. The authors concluded that aspiration therapy appeared to be a safe and effective long-term weight loss therapy for obesity. These preliminary findings from a pilot study need to be validated by well-designed studies.

Forssell and you will Noren (2015) examined the effectiveness of a novel tool, new AspireAssist ambition treatment system, for the treatment of being obese. Immediately after 4 weeks taking a highly-low-calorie diet plan, twenty-five fat men and women (Bmi 39.8 ± 0.9 kilogram/m(2)) met with the AspireAssist gastrostomy tube placed while in the an excellent gastroscopy. A decreased-character device try hung two weeks later and aspiration out-of gastric content is actually did up to 20 minutes shortly after edibles three times for each and every big date. Cognitive behavioral treatment was also started. Within week 6, indicate weight missing are 16.5 ± eight.8 kilogram on twenty two sufferers whom completed 26 weeks off procedures (p = 0.001). The imply payment EWL is forty.8 ± 19.8 % (p = 0.001); 2 subjects had been hospitalized to possess challenge: step 1 subject for soreness shortly after gastrostomy tube positioning, that has been addressed with analgesics, and one due to a keen aseptic intra-intestinal fluid range twenty four hours once gastrostomy tube position. No medically extreme changes in serum potassium or any other electrolytes happened. The article authors figured within analysis, nice dieting try hit with pair difficulties making use of the AspireAssist program, indicating its potential while the a nice-looking healing tool to possess obese patients.

Effective aspiration necessary comprehensive chewing from taken dining

In a prospective observational study, Noren and Forssell (2016) evaluated the safety and effectiveness of the novel AspireAssist Aspiration Therapy System for treatment of obesity, and its effect on patient’s quality of life. A total of 25 obese subjects, mean age of 48 years (range of 33 to 65) were included in this study. A custom gastrostomy tube (A-tube) was percutaneously inserted during a gastroscopy performed under conscious sedation. Drainage and irrigation of the stomach were performed 3 times daily, 20 mins after each meal, for 1 to 2 years. Treatment included a cognitive behavioral weight loss program. Mean BMI at inclusion was 39.8 kg/m2 (range of 35 to 49). After 1 year mean (SD) BMI was 32.1 kg/m2 (5.4), p < 0.01, and EWL was 54.4 % (28.8), p < 0.01. Quality of life, as measured with EQ-5D, improved from 0.73 (0.27) to 0.88 (0.13), p < 0.01. After 2 years BMI was 31.0 kg/m2 (5.1), p < 0.01, and EWL was 61.5 % (28.5), p < 0.01. There were no serious AEs or electrolyte disorderspliance was 80 % after 1 year and 60 % after 2 years. The authors concluded that aspiration therapy is a safe and efficient treatment for obesity, and weight reduction improves quality of life. Excess weight was approximately halved in a year, with weight stability if treatment was continued; and long-term results remain to be investigated.


您的电子邮箱地址不会被公开。 必填项已用*标注